Showing: 1 - 2 of 2 RESULTS

Fourth SoCal Whole Foods Worker Tests Positive For Coronavirus

SANTA MONICA, CA — Another Whole Foods Market worker in Santa Monica has tested positive for the coronavirus — the fourth employee at one of the grocery chain’s smallest locations in the U.S. to test positive in the last several months.

The worker is in quarantine and apparently did not get sick at the store, according to an employee at the 1425 Montana Ave. location who spoke with Patch.

Employees have complained that the location is small and makes it difficult to socially distance between customers and workers. The store is so small that the employees have a separate break room off-site, in an area separate from the store.

Essential workers have faced some of the greatest risk throughout the pandemic. Whole Foods workers are Amazon employees and have no union representation. Patch reached out to CAL/OSHA for more information about this location.

Patch reached out to Whole Foods Market for a statement of how it is responding to the ongoing cases, with the most recent known and disclosed case in July.

“We have had positive COVID-19 cases in this location since the start of the pandemic, but are not able to share details out of respect for the privacy of our team members,” a Whole Foods Market spokesperson told Patch.

Employees at this Whole Foods location receive text message alerts when a team member tests positive for the coronavirus.

Store officials report the location has had “a professional deep cleaning and disinfection since the last diagnosis of COVID-19 in this location. Not sure where you received the info that this store is the smallest in the company, but that’s not verified,” the spokesperson said.

Patch asked this spokesperson, who is in Texas, whether they have visited the location. It appears they have not.

Whole Foods continues to release the following statement to Patch:

“The safety of our Team Members and customers is our top priority and we are diligently following all guidance from local health and food safety authorities. We’ve been working closely with our store Team Members, and are supporting the diagnosed Team Member, who is in quarantine. Out of an abundance of caution, the store has performed a professional deep cleaning and disinfection, on top of our current enhanced sanitation measures. All Whole Foods Market stores continue to operate under social distancing and crowd control measures. Additionally, we have installed plexiglass barriers at check out, are requiring temperature checks and face masks for anyone working in our stores, and have implemented enhanced daily cleanliness and disinfection protocols in all of our stores.”

“Any time we learn of a presumed or confirmed diagnosis in any of our stores or facilities, we activate a set plan to protect the privacy of the impacted person while also mitigating any potential risks to our Team Members and customers. That plan includes comprehensive cleaning, contact tracing and a formal notification processes for those working in our stores. There is no higher priority for us than ensuring the health and safety

Fourth Bioelectronic Medicine Summit Showcases Broad Innovation

MANHASSET, N.Y.–(BUSINESS WIRE)–Sep 28, 2020–

Some of the most influential international experts, researchers, and scientific minds participated in the Fourth Bioelectronic Medicine Summit: Technology Targeting Molecular Mechanisms, hosted by The Feinstein Institutes for Medical Research – the global scientific home of bioelectronic medicine – on September 23 and 24.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200928005523/en/

Drs. Kevin Tracey, Valentin Pavlov, Sangeeta Chavan welcome participants to the 2020 Bioelectronic Medicine Summit (Credit: Feinstein Institutes)

Bioelectronic medicine combines molecular medicine, neuroscience, and biomedical engineering to develop innovative therapies to treat a variety of diseases and conditions through targeted stimulation of nerves, including paralysis, arthritis, pulmonary hypertension, and inflammatory bowel disease. Due to coronavirus disease 2019 (COVID-19), this year’s summit was held virtually and drew nearly 200 attendees, including esteemed academic leaders, members of the media, and industry professionals.

“Even though our recent focus has been on discovering a COVID-19 treatment, we continue to research, invest and lead in bioelectronic medicine,” said Kevin J. Tracey, MD, president and CEO of the Feinstein Institutes. “It was an honor to bring together some of the most influential experts to explore, define, and propel this exciting field of science even further.”

Key highlights from the symposium include:

  • Gene Civillico, PhD, National Institutes of Health, discussed SPARC and the need to openly share data amongst the science community to promote innovation;
  • Chris Puleo, PhD, General Electric, described a non-invasive method of using ultrasound to modify neuromodulation;
  • David Chernoff, MD, SetPoint Medical, explained how research is going from the bench to the bedside in cutting-edge clinical trials to treat autoimmune diseases;
  • Kip Ludwig, PhD, University of Wisconsin, reviewed the steps needed to translate bioelectronic medicine to be used more effectively in humans;
  • Lawrence Steinman, MD, Stanford Medicine, delivered the keynote address discussing amyloid proteins and the neuroimmune regulatory pathway.

“It is exciting to hear, and see first-hand from the people leading progress in bioelectronic medicine,” said Valentin Pavlov, PhD, professor in the Feinstein Institutes’ Institute of Bioelectronic Medicine and co-chair of the summit. “It is important that collectively, researchers from around the globe continue to share their knowledge and help evolve this flourishing and promising field of science.”

Breakthroughs in engineering such as miniature electrodes, flexible sensors, methods of controlling and observing vagus nerve stimulation were among the presentation topics. In addition to video presentations, exhibitions, Q&A sessions, and networking opportunities, more than 23 research poster abstracts were displayed – giving attendees a glimpse into what’s on the horizon for bioelectronic medicine.

“We are at the forefront of a medical and technological revolution,” said Sangeeta Chavan, PhD, professor in the Feinstein Institutes’ Institute of Bioelectronic Medicine and co-chair of the summit. “These lectures, presentations and open-dialogue conversations strengthen our view that bioelectronic medicine will treat the world’s most complex disorders, potentially even better than pharmacologics.”


About the Feinstein Institutes


The Feinstein Institutes for Medical Research

is the research arm of Northwell Health, the largest health care provider and private employer in New